| Title | Cancer and Chemotherapy Reviews |
| Standard Abbreviation | Cancer Chemother. Rev. |
| Type of Publication | Journal |
| Discipline | Oncology (Q4); Pharmacology (medical) (Q4) |
| Impact Score | 0.19 |
| SCImago Journal Rank (SJR) | 0.119 |
| h-index | 3 |
| Overall Rank | 24281 |
| Publisher Name | Publicaciones Permanyer |
| Publication Country | Spain |
| International Standard Serial Number (ISSN) | 1885740X |
| Coverage and History | 2007-2021 |
| Best Quartile | Q4 |
| Total Citations Received (Last 3 Year) |
3 |
Cancer and Chemotherapy Reviews is a journal published by Publicaciones Permanyer. This journal covers the area[s] related to Oncology, Pharmacology (medical), etc.
The coverage history of this journal is as follows: 2007-2021.
The rank of this journal is 24281. This journal's impact score, h-index, and SJR are 0.19, 3, and 0.119, respectively. The ISSN of this journal is/are as follows: 1885740X.
The best quartile of Cancer and Chemotherapy Reviews is Q4.
This journal has received a total of 3 citations during the last three years (Preceding 2022).
The latest impact score (IS) of the Cancer and Chemotherapy Reviews is 0.19. It is computed in the year 2023 as per its definition and based on Scopus data.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact Score 2022 of Cancer and Chemotherapy Reviews is 0.19. If a similar upward trend continues, IS may increase in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.19 |
| 2021 | 0.00 |
| 2020 | 0.33 |
| 2019 | 0.06 |
| 2018 | 0.09 |
| 2017 | 0.00 |
| 2016 | 0.00 |
| 2015 | 0.00 |
| 2014 | 0.03 |
The h-index of Cancer and Chemotherapy Reviews is 3. By definition of the h-index, this journal has at least 3 published articles with more than 3 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of Cancer and Chemotherapy Reviews is/are as follows: 1885740X.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The Cancer and Chemotherapy Reviews is ranked 24281 among 27955 Journals, Conferences, and Book Series.
As per SJR, this journal is ranked 0.119.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of Cancer and Chemotherapy Reviews is Publicaciones Permanyer. The publishing house of this journal is located in the Spain. Its coverage history is as follows: 2007-2021.
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
The International Organization for Standardization 4 (ISO 4) abbreviation of Cancer and Chemotherapy Reviews is Cancer Chemother. Rev.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).
As ISO 4 is an international standard, the abbreviation ('Cancer Chemother. Rev.') can be used for citing, indexing, abstraction, and referencing purposes.
If your area of research or discipline is related to Oncology, Pharmacology (medical), etc., please check the journal's official website to understand the complete publication process.
There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:
The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.
The latest impact score of Cancer and Chemotherapy Reviews is 0.19. It is computed in the year 2023.
The latest h-index of Cancer and Chemotherapy Reviews is 3. It is evaluated in the year 2023.
The latest SCImago Journal Rank (SJR) of Cancer and Chemotherapy Reviews is 0.119. It is calculated in the year 2023.
The latest ranking of Cancer and Chemotherapy Reviews is 24281. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.
Cancer and Chemotherapy Reviews is published by Publicaciones Permanyer. The publication country of this journal is Spain.
This standard abbreviation of Cancer and Chemotherapy Reviews is Cancer Chemother. Rev..
Cancer and Chemotherapy Reviews is a journal published by Publicaciones Permanyer.
The scope of Cancer and Chemotherapy Reviews is as follows:
For detailed scope of Cancer and Chemotherapy Reviews, check the official website of this journal.
The International Standard Serial Number (ISSN) of Cancer and Chemotherapy Reviews is/are as follows: 1885740X.
The best quartile for Cancer and Chemotherapy Reviews is Q4.
The coverage history of Cancer and Chemotherapy Reviews is as follows 2007-2021.
Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
| Journal/Conference/Book Title | Type | Publisher | Ranking | SJR | h-index | Impact Score |
|---|---|---|---|---|---|---|
| Dermatologia Kliniczna | Journal | Cornetis | 25442 | 7 | 0.00 | |
| Indian Journal of Plastic Surgery | Journal | Thieme Medical Publishers Inc. | 16018 | 37 | 0.65 | |
| Journal of Education and Work | Journal | Brill Academic Publishers | 9268 | 43 | 1.93 | |
| Socialism and Democracy | Journal | Taylor and Francis Ltd. | 26162 | 17 | 0.09 | |
| Sapporo Medical Journal | Journal | Cancer Research Institute, Sapporo Medical University | 20468 | 3 | 0.00 | |
| Proceedings of the International Semiconductor Conference, CAS | Conference And Proceedings | Institute of Electrical and Electronics Engineers Inc. | 25734 | 16 | 0.00 | |
| Museum Management and Curatorship | Journal | Routledge | 8168 | 37 | 2.65 | |
| Journal of Immigrant and Refugee Studies | Journal | Routledge | 9246 | 32 | 1.46 | |
| Rudarsko Geolosko Naftni Zbornik | Journal | University of Zagreb, Faculty of Mining, Geology and Petroleum Engineering | 14294 | 17 | 1.48 | |
| Brazilian Symposium of Computer Graphic and Image Processing | Conference And Proceedings | 16004 | 32 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Updated Soon |
| 2022 | 0.19 |
| 2021 | 0.00 |
| 2020 | 0.33 |
| 2019 | 0.06 |
| 2018 | 0.09 |
| 2017 | 0.00 |
| 2016 | 0.00 |
| 2015 | 0.00 |
| 2014 | 0.03 |
0.19
0.119
3
24281
